Project description:We have reviewed the pivotal presentations in non-small cell lung cancer (NSCLC) from the 2009 annual meeting of the American Society of Clinical Oncology. We have discussed the scientific data, the impact on standards of care, and ongoing clinical trials.In patients with early-stage NSCLC, there is still no data to support the superiority of either neoadjuvant or adjuvant chemotherapy. However, adjuvant cisplatin-based chemotherapy has sustained the survival benefits after median follow-up of more than 9 years. The first-line treatment with inhibitors of epidermal growth factor receptor (EGFR) could be considered for the treatment of EGFR mutated patients with metastatic disease.Several maintenance studies with cytotoxic or biological agents have also demonstrated promising outcomes. Finally, novel targeted agents such as inhibitors of histone deacetylase and multi-targeted tyrosine kinase inhibitor have shown promising activity in NSCLC treatment.

| S-EPMC2876054 | biostudies-literature

British Society of Gastroenterology Annual Meeting, 20-23 March 2006, Birmingham, England, United Kingdom. Abstracts.

Project description: Not available

| S-EPMC1859999 | biostudies-literature

American Society of Hematology 2015 Annual Meeting.

Project description:The annual meeting of the American Society of Hematology drew 25,000 attendees for the presentation of 5,633 abstracts. We review key sessions focusing on newer agents and their efficacy in high-risk leukemia and multiple myeloma populations.

| S-EPMC4745640 | biostudies-literature

Irish Thoracic Society Annual Scientific Meeting 2020.

Project description: Not available

| S-EPMC7788179 | biostudies-literature

20th IUPAB International Congress, 45th SBBf Congress and 50th Annual Meeting of SBBq : Poster Abstracts

Project description: Not available

| S-EPMC8551951 | biostudies-literature